Assignee
DOMAIN THERAPEUTICS
FR·5 granted patents·5 pending applications·6 citations·filing 2013–2023
Top patents by PatentIndex Score
10 records- 0182US11008323B2Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2016·Granted May 18, 2021·5 cites·13 claims
- 0263US9434734B2Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2013·Granted Sep 6, 2016·1 cites·15 claims
- 0350US2025320224A1Novel par-2 inhibitorsDOMAIN THERAPEUTICS·Filed 2023·Application pending·0 cites
- 0446US2019152979A1Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0544US2022089609A1Substituted quinazolinone derivatives and their use as positive allosteric modulators of mglur4DOMAIN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0644US2024066027A1Novel par-2 inhibitorsDOMAIN THERAPEUTICS·Filed 2021·Application pending·0 cites
- 0743US12527779B2Prostaglandin E2 (PGE2) EP4 receptor antagonistsDOMAIN THERAPEUTICS·Filed 2020·Granted Jan 20, 2026·0 cites·26 claims
- 0838US10221179B2Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2015·Granted Mar 5, 2019·0 cites·21 claims
- 0938US2022298135A15-heteroaryl-pyridin-2-amine compounds as neuropeptide ff receptor antagonistsDOMAIN THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1031US11472806B2Substituted heterocyclic compounds as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2018·Granted Oct 18, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when DOMAIN THERAPEUTICS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →